January 17, 2017
Cocaine and amphetamine use are linked to a higher risk of intracerebral hemorrhage, but guidelines recommending drug screening for those stroke patients often aren't followed.
IU-based startup Arrhythmotech awarded $1.47M NIH grant to study atrial fibrillation, nerve activityJuly 21, 2016
The life sciences company based on Indiana University technology will use the two-year grant from the National Institutes of Health to determine if nerve activity is associated with atrial fibrillation, a common heart-rhythm disorder.
June 20, 2016
Indiana University announced that the Precision Health Initiative, a research initiative focused on patient-centered precision medicine therapies, is the first recipient of funding under the universitys new $300 million Grand Challenges Program.
March 10, 2016
Here's a new recipe for creating living tissue: Impale tiny clumps of cells onto needles, much like miniature shish kebab skewers. Instead of heading to a tiny BBQ grill, you wait while the cells grow together to form the tissue you want -- perhaps skin, or a section of blood vessel. Researchers at Indiana University are among the first in the United States to have direct access to a 3D bioprinter using that innovative technology to create living tissue.
January 8, 2016
IUSM proposal one of five finalists for IU Grand Challenges program
September 15, 2015
The National Center of Excellence in Womens Health, a program of the Indiana University School of Medicine and the Department of Obstetrics and Gynecology, received $413,000 in Title V grant funds for the first time from the Indiana State Department of Health.
August 31, 2015
The Indiana University School of Medicine has been selected to lead a five-year, $12 million national research project to develop new treatments for diseases of a genetic mutation that leads to disfiguring and life-threatening tumors and other developmental disorders, mainly in children.
July 31, 2015
Indiana University-Purdue University Indianapolis researchers led by Jesse Stewart of the School of Science, have received a $2.6 million grant from the National Institutes of Health to conduct the first randomized controlled trial to determine whether depression treatment can help prevent the development of cardiovascular disease.